Type B hepatitis: progression to chronic hepatitis
Wright, R.
Clinics in Gastroenterology 9(1): 97-115
1980
ISSN/ISBN: 0300-5089 PMID: 6994954 Document Number: 155755
The ability to test for HBV associated antigens has provided evidence that viral hepatitis is a common cause of chronic liver disease world-wide. Fewer than 10% of cases of acute icteric HBV become chronic, but chronicity is more common after anicteric infections. The prognosis for chronic persistent hepatitis B is usually good whereas many cases of chronic active hepatitis B will progress to cirrhosis although the time scale may be long. Factors determing the severity of the liver disease and the progression to chronicity are unclear, but the immune response of the host to the infection seems to play a major role.
Document emailed within 1 workday
Related Documents
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952Tsuji, K.; Hasebe, C.; Murazumi, Y.; Yosida, Y.; Kanai, M.; Ohta, H.; Ohhira, M.; Kohda, H.; Ono, M.; Yazaki, Y. 1991: A case of type B chronic hepatitis showing rapid progression to liver cirrhosis with prolonged positive IgM anti-HBc Hokkaido Journal of Medical Science 66(4): 575-581
Gordon, S.C.; Kodali, V.P.; Silverman, A.L.; Dmuchowski, C.F.; Urdea, M.S.; Chan, C.S.; Wilber, J.C. 1994: Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis American Journal of Gastroenterology 89(9): 1458-1461
Lai, M.Y.; Chen, D.S.; Lee, S.C.; Su, I.J.; Yang, P.M.; Hsu, H.C.; Sung, J.L. 1988: Reactivation of hepatitis B virus in anti-HBe-positive chronic active type B hepatitis: molecular and immunohistochemical studies Hepato-Gastroenterology 35(1): 17-21
Rakela, J.; Redeker, A.G.; Weliky, B. 1983: Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis Gastroenterology 84(5 Part 1): 956-960
Da Silva, L.C.; Mattar, E.; Carrilho, F.J.; Takeda, A.; Sette Júnior, H.; Gayotto, L.C. 1983: Disappearance of hepatitis B surface antigen in chronic type B hepatitis after clinical and laboratorial relapse produced by abrupt withdrawal of immunosuppressive drugs Revista do Instituto de Medicina Tropical de Sao Paulo 25(6): 270-274
Zhang, X.; Xiong, S.; Lu, Z. 1997: Quantitative detection of serum hepatitis B wild type virus and the precore mutant genomes using competitive polymerase chain reaction in patients with HBeAg(-) chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 11(1): 33-36
Lopatkina, T.N.; Strizhakov, L.A.; Tanashchuk, E.L.; Konysheva, A.A.; Moiseev, S.V. 2015: The Influence of Chronic Hepatitis C on Atherosclerosis Progression Klinicheskaia Meditsina 93(2): 9-13
Tassopoulos, N.C.; Papatheodoridis, G.V.; Katsoulidou, A.; Delladetsima, J.K.; Sypsa, V.; Touloumi, G.; Nikandros, M.; Hatzakis, A. 1998: Factors associated with severity and disease progression in chronic hepatitis C Hepato-Gastroenterology 45(23): 1678-1683
Lobello, S.; Lorenzoni, U.; Vian, A.; Floreani, A.; Brunetto, M.R.; Chiaramonte, M. 1998: Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring Journal of Viral Hepatitis 5(1): 61-66
Pol, S.; Corouge, M.; Mallet, V.; Sogni, P. 2013: Rapid progression of antiviral treatments of chronic hepatitis C virus infection Minerva Gastroenterologica E Dietologica 59(2): 161-172
Perrillo, R.P.; Brunt, E.M. 1991: Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen Annals of Internal Medicine 115(2): 113-115
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Wang, C-Shan.; Wang, S-Tair.; Chang, T-Tsung.; Yao, W-Jen.; Chou, P. 2002: Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression Archives of Internal Medicine 162(7): 811-815
Sonnabend, W.; Kistler, G.S.; Thiel, G.; Zollinger, H.U.; Bianchi, L.; Enderlin, F.; Gudat, F.; Krech, U. 1974: Chronic focal glomerulonephritis and chronic persistent hepatitis following kidney transplantation. Detection of Hepatitis B and Epstein-Barr virus antigen Schweizerische Medizinische Wochenschrift 104(35): 1205-1217
Pirotte, J.; Rauber, G.; Ruyters, L. 1972: Chronic persistent hepatitis and chronic active hepatitis. Correlations between the histological aspects, clinical picture, biological and immunological data Archives Francaises des Maladies de l'Appareil Digestif 61(1): 7-18
Juszczyk, J. 2003: Place of consensus type interferon alpha in the management of chronic type C hepatitis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(82): 275-278
Guido, M.; Rugge, M.; Colombari, R.; Cecchetto, A.; Scarpa, A.; Cadrobbi, P. 1998: Prompt hepatitis C virus suppression following hepatitis B virus superinfection in chronic untreated hepatitis C Italian Journal of Gastroenterology and Hepatology 30(4): 414-417
Schoeman, M.N.; Liddle, C.; Bilous, M.; Grierson, J.; Craig, P.I.; Batey, R.G.; Farrell, G.C. 1990: Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression Australian and New Zealand Journal of Medicine 20(1): 56-62
Numata, N.; Kanno, A.; Ohori, H. 1995: Demonstration of hepatitis C virus genome in saliva and urine of patients with type C hepatitis Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 477-482